Medicine and Dentistry
Psychosis
100%
Patient
74%
Symptom
49%
Diagnosis
30%
Follow up
27%
Body Mass Index
26%
Therapeutic Procedure
23%
Association
22%
Treatment Response
21%
Obesity
19%
Biological Marker
15%
Lifestyle
14%
Cannabis Use
14%
Health
14%
Reducing Agent
14%
Prospective Cohort Study
14%
Brain Derived Neurotrophic Factor
14%
Hydrocortisone
14%
Drug Therapy
14%
Repetitive Transcranial Magnetic Stimulation
14%
Health Promotion
14%
Treatment Resistant Depression
14%
Vitamin D Deficiency
14%
Insulin Resistance
14%
Cardiometabolic Risk
14%
Male
14%
Randomized Controlled Trial
14%
Paranoid Psychosis
14%
Disease
12%
Spontaneous Remission
12%
Clinician
12%
Hemoglobin A1c
9%
Female
8%
Antipsychotics
7%
Mental Health
7%
Waist-Hip Ratio
6%
Student T Test
5%
Saliva
5%
Dysphoria
5%
Positive Syndrome
5%
Side Effect
5%
Marker
5%
Cannabis
5%
Neuroscience
Brain
40%
Brain-Derived Neurotrophic Factor
29%
Body Mass Index
28%
Gyrification
28%
Risperidone
19%
Bipolar Disorder
17%
Antipsychotic
16%
Olanzapine
16%
Cortisol
14%
Major Depressive Disorder
14%
White Matter
14%
Escitalopram
14%
Insulin
14%
Venlafaxine
14%
Treatment-Resistant Depression
14%
Connectomics
14%
Sertraline
14%
Valproic Acid
14%
Cholesterol
9%
Interleukin 6
8%
Interferon
8%
Prolactin
6%
Antidepressant
5%
C-Reactive Protein
5%
Diffusion Tensor Imaging
5%
Pediatric Trauma
5%
Psychology
Schizophrenia
35%
Longitudinal Study
32%
Cognitive Function
21%
Psychotic Disorder
19%
Schizoaffective Disorder
15%
Traumatic Event
14%
Bipolar Disorder
14%
Memory Impairment
14%
Regression Analysis
14%
Neuropsychological Deficit
14%
Clinical Utility
14%
Hallucinations
14%
Rating Scale
11%
Principal Component Analysis
9%
Physical Health
9%
High-Risk Population
8%
Human Brain
7%
Cognitive Process
7%
Cognitive Deficit
7%
Brain Plasticity
7%
